Filing Flows

Filing Flows › Comparisons › MOBI vs APYX

Mobia Medical vs Apyx Medical: MOBI and APYX compared

Mobia Medical is the larger company: $15.6M of revenue in its latest quarter (Q3 2026) against $14.0M for Apyx Medical (Q3 2026). Mobia Medical is growing faster (+73% against +9% a year earlier). Apyx Medical is more profitable, with an operating margin of -4.1% against -118.7%.

Mobia Medical vs Apyx Medical, latest quarterMobia Medical vs Apyx Medical, latest quarterMobia Medical (MOBI)Apyx Medical (APYX)Revenue$15.6M$14.0MRevenue growth, Y/Y+73%+9%Operating margin-118.7%-4.1%Net margin-111.1%-12.9%

Where the money goes: MOBI and APYX

Mobia Medical (MOBI) · Q3 2026

Mobia Medical, Q3 2026: revenue $15.6M (+73% year over year), operating margin -118.7%, net loss $17.3M, operating cash flow −$12.9M. The chart follows the revenue to costs, profit and cash.

Apyx Medical (APYX) · Q3 2026

Apyx Medical, Q3 2026: revenue $14.0M (+9% year over year), operating margin -4.1%, net loss $1.8M, operating cash flow −$1.6M. The chart follows the revenue to costs, profit and cash.

Mobia Medical (MOBI)Apyx Medical (APYX)
Latest quarterQ3 2026Q3 2026
Revenue$15.6M$14.0M
Revenue growth, Y/Y+73%+9%
Operating margin-118.7%-4.1%
Net earnings−$17.3M−$1.8M
Net margin-111.1%-12.9%
Operating cash flow−$12.9M−$1.6M

Questions

Which is bigger, Mobia Medical or Apyx Medical?

Mobia Medical is the larger company: $15.6M of revenue in its latest quarter (Q3 2026) against $14.0M for Apyx Medical (Q3 2026).

Is Mobia Medical or Apyx Medical growing faster?

Mobia Medical is growing faster (+73% against +9% a year earlier).

Which is more profitable, Mobia Medical or Apyx Medical?

Apyx Medical is more profitable, with an operating margin of -4.1% against -118.7%.

More: Mobia Medical earnings · how Mobia Medical makes money · Apyx Medical earnings · how Apyx Medical makes money

From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.